All hands on deck: COVID-19 engineering response team assembles from every corner at Duke
Date Published:
DURHAM – At the beginning of 2020, Dr. Alejandro Pino’s attention was focused on designing and patenting feeding tubes that…
Life Sciences
Grifols begins accepting plasma from recovered COVID-19 patients
Date Published:
Grifols is now accepting plasma from volunteer donors who have recovered from the COVID-19 virus at its Raleigh area locations.…
Durham pharma company to test its experimental cancer drug on COVID-19 patients
Date Published:
A Durham-based biopharmaceutical company says it has gotten the okay from the Food and Drug Administration to test its experimental…
Flush with $22M, newly merged 9 Meters Biopharma launches in Raleigh with focus on GI diseases
Date Published:
RALEIGH — Introducing 9 Meters Biopharma, the new company birthed from the merger of Raleigh-based Innovate Biopharmaceuticals, a clinical stage…
Durham’s Chimerix gets FDA nod to test cancer drug in COVID-19 patients
Date Published:
DURHAM — Chimerix has gotten the green light to test an investigational cancer drug to treat COVID-19 patients.
The Durham-based…
Gene therapy firm AskBio acquires French company targeting deadly brain disease
Date Published:
RESEARCH TRIANGLE PARK – Asklepios BioPharmaceutical (AskBio), a clinical stage gene therapy company in Research Triangle Park, has acquired BrainVectis,…
Raleigh pharma to have second drug tested for potential COVID-19 treatment
Date Published:
With fresh data from existing trials treating COVID-19 patients in Italy and Israel, a Triangle drugmaker has announced a deal…
RedHill Biopharma, which has US HQ in Raleigh, pursues second COVID-19 treatment
Date Published:
RALEIGH – RedHill Biopharma is another step closer to getting one of its potential treatments for COVID-19 tested.
The Israeli…
LabCorp receives FDA approval to sell at-home COVID-19 test
Date Published:
BURLINGTON – Health services giant LabCorp will begin selling an at-home test for the COVID-19 virus after receiving emergency authorization…